The withdrawal of US support threatens to make eradication targets unattainable
For decades, American dollars formed the backbone of the global fight against tuberculosis — a disease that still claims a life every fifteen seconds. When the Trump administration froze foreign aid and dismantled the architecture of USAID early in 2025, it did not merely cut a budget line; it withdrew the foundation beneath programmes serving millions of the world's most vulnerable people. A new study now places a number on that absence: between 100,000 and 2.2 million additional deaths by 2030, a toll that will fall heaviest on those least responsible for the decision that caused it.
- The US funded more than half of all external TB support worldwide — and then, almost overnight, terminated over 80% of USAID contracts, leaving treatment programmes across 26 high-burden countries without their primary source of survival.
- Researchers modelling the fallout project a worst-case scenario of 10.67 million additional TB cases and 2.2 million deaths by 2030 — but even the most optimistic recovery path still yields 100,000 preventable deaths.
- The WHO's 2030 End TB target, already a stretch goal, now looks like a casualty of geopolitics, as diagnostics, treatment regimens, and HIV-TB co-infection programmes lose the funding that kept them running.
- Scientists and health advocates are urgently calling on domestic governments, bilateral donors, and multilateral agencies to fill the gap — but mobilising replacement capital takes months that the disease will not wait for.
When the Trump administration froze American foreign aid in January, it cut the financial lifeline for tuberculosis programmes across the developing world. A study published in PLOS Global Public Health has since put a number on the damage: between 100,000 and 2.2 million additional TB deaths over the next five years, depending on how swiftly services can be restored.
The United States had been funding at least 55 per cent of all external TB support globally as 2024 closed — a dominance built over decades of commitment to fighting one of humanity's oldest infectious diseases. The administration's justification for the reversal was blunt: USAID had strayed from its core mission and was delivering too little for too much money. More than 5,800 grants were cancelled in the process.
Researchers modelled the consequences across 26 high-burden countries. In the worst case — where lost funding translates directly into collapsed treatment capacity with no recovery — the toll reaches 10.67 million additional cases and 2.2 million deaths by 2030. Even the optimistic scenario, assuming services are restored within three months, still projects 630,000 extra cases and roughly 100,000 deaths.
The cruelty of the timing is hard to overstate. The WHO had set 2030 as the year for eradicating TB globally, a target now in serious jeopardy. TB diagnostics, treatment, HIV co-infection care, and research into new tools all depended on the funding that has now evaporated. The study calls urgently for domestic budgets, bilateral donors, and multilateral agencies to fill the void — but the disease kills roughly one person every fifteen seconds, and it will not pause while the world deliberates.
When the Trump administration froze American foreign aid in January, it severed the financial lifeline for tuberculosis programmes across the developing world. A new study published in PLOS Global Public Health has quantified what that rupture means: somewhere between 100,000 and 2.2 million additional deaths from TB over the next five years, depending on how quickly the damage can be repaired.
The United States was bankrolling more than half of all external funding for global TB efforts as 2024 ended—at least 55 per cent of the total. That dominance reflected decades of American commitment to fighting one of the world's oldest infectious diseases. Then, in a sweeping action, the administration terminated over 80 per cent of contracts managed by the United States Agency for International Development, the government's primary vehicle for humanitarian work abroad. The justification was blunt: USAID had drifted from its core purpose and was delivering too little for too much money. More than 5,800 global grants were cancelled in the process.
Researchers modelled the fallout across 26 countries where tuberculosis remains a major killer. Their worst-case projection—assuming funding cuts translate directly into lost treatment capacity and that services don't recover—shows 10.67 million additional TB cases and 2.2 million deaths between 2025 and 2030. Even in the most optimistic scenario, where programmes manage to restore services within three months, the toll would still be staggering: 630,000 extra cases and roughly 100,000 deaths. A middle ground assumes partial recovery, yielding 1.66 million additional cases and 270,000 deaths.
The timing is particularly cruel. The World Health Organisation has set 2030 as the target year for eradicating TB globally—a goal now in jeopardy. TB diagnostics, treatment regimens, interventions for patients with both TB and HIV, and research into new tools all depend on the funding that has now evaporated. The researchers note that pre-existing gaps in TB financing, already a chronic problem, have only widened. Vulnerable populations in the hardest-hit countries will suffer first and most severely.
What happens next depends on whether alternative sources of money can be found quickly. The study calls for urgent funding from domestic budgets in affected countries, from other international donors, and from multilateral agencies. But mobilising that capital takes time, and TB doesn't wait. The disease kills roughly one person every 15 seconds globally. Every month of disrupted services means more infections, more deaths, and a steeper climb toward the 2030 target. The question now is whether the world can move fast enough to fill the hole that American withdrawal has left behind.
Citas Notables
The withdrawal of US government support threatens the development of critical new tools, further delaying progress and making End TB targets unattainable— Researchers in PLOS Global Public Health study
USAID had strayed from its original mission with too few gains and too high costs— Trump administration justification for aid cuts
La Conversación del Hearth Otra perspectiva de la historia
Why does American funding matter so much for TB programmes? Couldn't other countries or organisations step in?
The US wasn't just one donor among many—it was funding more than half of all external TB work globally. That's not a preference; it's structural dependence. Other donors exist, but mobilising them takes months or years, and TB doesn't pause.
The study gives three scenarios. What separates the best case from the worst?
Speed of recovery. If programmes can restore services within three months, the damage is contained to roughly 100,000 deaths. If cuts persist for years, it balloons to 2.2 million. The difference is whether the world can act fast enough to fill the gap.
The administration said USAID had strayed from its mission. Is that claim supported by the evidence?
That's a separate argument. What the study shows is that regardless of USAID's efficiency or mission drift, the practical effect of cutting 80 per cent of contracts is that TB programmes lose their funding. The justification doesn't change the outcome on the ground.
Which countries are most vulnerable?
The study looked at 26 high-burden TB countries, but it doesn't name them individually. What matters is that they're places where TB is already entrenched and where health systems are fragile. They can't absorb this shock.
Is there any silver lining here?
The study itself is a silver lining in a way—it's forcing the conversation into the open. Researchers are calling for urgent alternative funding. That call might actually mobilise other donors. But it's a race against time.